Kancer Ltd

Kancer is focussed on the development of new products based upon the reformulation of existing approved therapies and breakthrough treatments for cancer.

Our strategic aim is that:“Kancer will be a leading international development based company in cancer therapies by 2012”

Kancer's founders Dr New and Glen Travers , have been working in the fields of drug delivery and discovery since 1980’s.  Prior to Kancer’s incorporation, both of the founders (Dr New and Mr Travers) led drug delivery programs at a leading biotechnology company between 1991 and 1998.

Website: www.kancer.co.uk

Key Projects

Kancer’s projects represent a balance of risk and technologies designed to increase the opportunity to make an impact on this disease:

• Oral GCSF (GMCSF) - white blood cell rebuilder;
• Oral Alpha Interferon - to treat Human Papiloma Virus;
• Photodynamic Therapy with Special Targetting - surface cancers ;
• Inducing Apoptosis - using Special Targetting amino acid constructs ;

• Cancer Vaccines - collaborations in development ;